Veradigm | MDRX - Net Income


Veradigm reported $-59.82M in Net Income for its fiscal quarter ending in December of 2022.





Net Income Change Date
Alcidion AUD 1.33M 1.21M Dec/2025
Ambu A/S DKK 121M 3M Mar/2026
Amplifon EUR 38.55M 28.03M Jun/2026
Cardinal Health USD 399M 68M Mar/2026
Centene USD 1.09B 450M Jun/2026
Charles River Laboratories USD -14.84M 261.71M Mar/2026
Cigna USD 1.66B 6M Jun/2026
Coloplast 1.4B 522M Dec/2025
Convatec Group USD 111.9M 72.6M Dec/2024
CVS Health USD 2.94B 0 Mar/2026
Diasorin EUR 38M 24.96M Mar/2026
Elevance Health USD 1.46B 301M Jun/2026
General Electric Aerospace USD 2.37B 466M Jun/2026
Gulf Medical Proj AED 30.2M 9.34M Dec/2025
Humana USD 694M 492M Jun/2026
IQVIA Holdings USD 256M 18M Jun/2026
Laboratory Of America USD 298.7M 20.9M Jun/2026
Maximus USD 98.06M 4.12M Mar/2026
McKesson USD 1.68B 496M Mar/2026
Med Life RON 7.24M 23.18M Sep/2025
Molina Healthcare USD 60M 46M Jun/2026
Omnicell USD 24.29M 12.93M Jun/2026
Oriola-kd EUR -2M 15.9M Mar/2026
Owens Minor USD -56.33M 93.95M Dec/2025
Quest Diagnostics USD 320M 69M Jun/2026
Rede D'or Sao Luiz BRL 967.33M 205.12M Mar/2026
Siemens Healthineers EUR 669M 163M Jun/2026
Sonova Holding CHF 188.5M 143.4M Dec/2025
Supermax Corporation Bhd MYR -41.14M 17.3M Mar/2026
UnitedHealth USD 5.48B 796M Jun/2026
Veeva Systems USD 260.94M 16.73M Mar/2026
Veradigm USD -59.82M 74.35M Dec/2022
Xerox USD -109M 19M Jun/2025